Abstract
CA 125, a glycoprotein derived from coelomic epithelium, is used primarily as a marker of epithelial ovarian cancer. However, elevated levels of serum CA 125 have also been detected in other benign and malignant disorders. This study describes a haemodialysis patient who contracted tuberculous peritonitis associated with hypercalcaemia, erythropoietin-resistant anaemia and elevated CA 125, which normalised gradually following antituberculosis treatment. Tuberculous peritonitis should be considered in the differential diagnosis of ascites with elevated serum CA 125. Additionally, CA 125 is a useful marker for monitoring response to tuberculous peritonitis treatment.
Original language | English |
---|---|
Pages (from-to) | 56-59 |
Number of pages | 4 |
Journal | International Journal of Clinical Practice |
Volume | 59 |
Issue number | SUPPL. 147 |
DOIs | |
State | Published - 04 2005 |
Externally published | Yes |
Keywords
- CA125
- Haemodialysis
- Hypercalcaemia
- Tuberculous peritonitis